Steve Watson is a British Heart Foundation Professor in Cardiovascular Sciences and Cellular Pharmacology.
Steve is Head of the Birmingham Platelet Group which consists of more than 40 researchers (>10 PIs) investigating haemostatic and non-haemostatic functions of platelets in health and disease.
Steve’s research interests focus on mechanisms of platelet activation by tyrosine kinase-linked receptors (notably CLEC-2, FcgammaRIIA, GPVI and PEAR1) and in developing novel antiplatelet agents that target these receptors in thrombi-inflammatory disease.